PMC:7161517 / 636-881 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":220,"end":224},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma12520"}],"text":"t the use of these agents may facilitate viral disease; thus, they should not be used in high-risk patients with cardiovascular disease. Based on the anti-inflammatory benefits of the upregulation of the ACE2/Ang1-7/Mas axis and previously demon"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":41,"end":54},"obj":"Disease"},{"id":"T7","span":{"begin":113,"end":135},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"}],"text":"t the use of these agents may facilitate viral disease; thus, they should not be used in high-risk patients with cardiovascular disease. Based on the anti-inflammatory benefits of the upregulation of the ACE2/Ang1-7/Mas axis and previously demon"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":113,"end":135},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":"t the use of these agents may facilitate viral disease; thus, they should not be used in high-risk patients with cardiovascular disease. Based on the anti-inflammatory benefits of the upregulation of the ACE2/Ang1-7/Mas axis and previously demon"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T22","span":{"begin":19,"end":25},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T23","span":{"begin":41,"end":46},"obj":"NCBITaxon:10239"},{"id":"T24","span":{"begin":113,"end":127},"obj":"UBERON:0004535"},{"id":"T25","span":{"begin":204,"end":208},"obj":"G_3;PG_10;PR:000003622"},{"id":"T26","span":{"begin":209,"end":213},"obj":"PR:000036013"},{"id":"T23807","span":{"begin":19,"end":25},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T85043","span":{"begin":41,"end":46},"obj":"NCBITaxon:10239"},{"id":"T68089","span":{"begin":113,"end":127},"obj":"UBERON:0004535"},{"id":"T69502","span":{"begin":204,"end":208},"obj":"G_3;PG_10;PR:000003622"},{"id":"T7389","span":{"begin":209,"end":213},"obj":"PR:000036013"}],"text":"t the use of these agents may facilitate viral disease; thus, they should not be used in high-risk patients with cardiovascular disease. Based on the anti-inflammatory benefits of the upregulation of the ACE2/Ang1-7/Mas axis and previously demon"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":204,"end":208},"obj":"Gene"},{"id":"30","span":{"begin":209,"end":215},"obj":"Gene"},{"id":"34","span":{"begin":99,"end":107},"obj":"Species"},{"id":"37","span":{"begin":41,"end":54},"obj":"Disease"},{"id":"38","span":{"begin":113,"end":135},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Gene:59272"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:284"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Tax:9606"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D001102"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"t the use of these agents may facilitate viral disease; thus, they should not be used in high-risk patients with cardiovascular disease. Based on the anti-inflammatory benefits of the upregulation of the ACE2/Ang1-7/Mas axis and previously demon"}